[Ossen Innovation Enters into Agreements to Acquire America-Asia Diabetes Research Transaction Details Upon completion of the Acquisition, the Company will indirectly own 90.27% of San MediTech. San MediTech's proprietary Dynamic Glucose Monitoring System ("DGMS") provides continuous, real-time monit]